Scarica l'app Stockscreener
6.98
1.97%
-0.14
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.12
Aprire:
$7.12
Volume 24 ore:
1.63M
Relative Volume:
1.35
Capitalizzazione di mercato:
$397.83M
Reddito:
$5.82M
Utile/perdita netta:
$71.18M
Rapporto P/E:
6.9996
EPS:
0.9972
Flusso di cassa netto:
$-84.30M
1 W Prestazione:
+9.06%
1M Prestazione:
+30.22%
6M Prestazione:
+34.49%
1 anno Prestazione:
+19.32%
Intervallo 1D:
$6.7509
$7.25
Intervallo di 1 settimana:
$6.22
$7.25
Portata 52W:
$4.00
$7.5401
Abeona Therapeutics Inc Stock (ABEO) Company Profile
Nome
Abeona Therapeutics Inc
Settore
Industria
Telefono
646-813-4701
Indirizzo
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, NY
Compare ABEO vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ABEO
Abeona Therapeutics Inc
|
6.98 | 397.83M | 5.82M | 71.18M | -84.30M | 0.9972 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Abeona Therapeutics Inc Stock (ABEO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-02 | Ripresa | Oppenheimer | Outperform |
| 2025-03-05 | Iniziato | Oppenheimer | Outperform |
| 2024-07-03 | Iniziato | H.C. Wainwright | Buy |
| 2024-05-30 | Iniziato | Stifel | Buy |
| 2020-11-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-09-18 | Iniziato | B. Riley FBR | Buy |
| 2020-02-10 | Iniziato | SVB Leerink | Outperform |
| 2019-12-10 | Ripresa | Cantor Fitzgerald | Neutral |
| 2019-08-15 | Downgrade | Maxim Group | Buy → Hold |
| 2019-08-12 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2019-07-26 | Downgrade | Mizuho | Buy → Neutral |
| 2019-06-27 | Iniziato | Mizuho | Buy |
| 2018-10-12 | Iniziato | Mizuho | Buy |
| 2018-06-05 | Iniziato | Seaport Global Securities | Buy |
| 2017-11-08 | Iniziato | SunTrust | Buy |
| 2017-10-16 | Reiterato | H.C. Wainwright | Buy |
| 2017-10-11 | Reiterato | Cantor Fitzgerald | Overweight |
| 2017-10-10 | Iniziato | Citigroup | Buy |
| 2017-10-05 | Reiterato | Maxim Group | Buy |
| 2017-09-15 | Iniziato | RBC Capital Mkts | Outperform |
| 2017-07-18 | Reiterato | Maxim Group | Buy |
| 2017-06-22 | Ripresa | Jefferies | Buy |
| 2017-01-06 | Iniziato | Jefferies | Buy |
| 2016-09-29 | Reiterato | Maxim Group | Buy |
Mostra tutto
Abeona Therapeutics Inc Borsa (ABEO) Ultime notizie
Abeona Therapeutics (NASDAQ: ABEO) shifts 760,870 warrants to SILV Fund - Stock Titan
Brendan O’Malley sells $83,912 in Abeona Therapeutics stock By Investing.com - Investing.com Australia
Form 4 Abeona Therapeutics Inc For: 9 July By Investing.com - Investing.com Nigeria
Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock By Investing.com - Investing.com Nigeria
Abeona Therapeutics CCO Vasanthavada Madhav sells $87,784 in stock - Investing.com UK
Abeona Therapeutics CEO Seshadri Vishwas sells $473k in stock - Investing.com
Abeona (ABEO) CFO sells 24,880 shares to cover taxes on vested stock - Stock Titan
Tax-related stock sale by Abeona (ABEO) CEO leaves 1.31M shares - Stock Titan
Abeona Therapeutics (ABEO) SVP sells shares to cover tax obligations - Stock Titan
Abeona Therapeutics (ABEO) CCO sells 12,606 shares, retains 290,623 - Stock Titan
Form 144 ABEONA THERAPEUTICS INC. For: 9 July By Investing.com - Investing.com South Africa
ABEO (NASDAQ) Form 144 shows 141,333 restricted shares planned for sale - Stock Titan
Insider share sales and RSAs reported by ABEO (NASDAQ: ABEO) - Stock Titan
ABEO (NASDAQ: ABEO) director reports proposed stock sales in Form 144 - Stock Titan
ABEO (Nasdaq: ABEO) files Form 144: 34,230 restricted shares; insider sales noted - Stock Titan
ABEO Q1 2026 Earnings: Narrowed Loss Surpasses Expectations as Stock Gains 3.82%Earnings Expansion Phase - dars.gov.et
ABEO (NASDAQ: ABEO) Rule 144 sale notice — 18,160 shares - Stock Titan
Abeona Therapeutics names Keith Goldan to board of directors - Investing.com
Price to sales forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Insider Sell Alert: Leila Alland Sells Shares of Abeona Therapeu - GuruFocus
Abeona Therapeutics (ABEO) director Alland Leila sells 11,000 shares - Stock Titan
ABEOAbeona Therapeutics Inc Latest SEC Filings - Finviz
Technical Reactions to ABEO Trends in Macro Strategies - Stock Traders Daily
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona gives 5 new hires restricted stock worth 9,000 shares - Stock Titan
Abeona Therapeutics Inc (ABEO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM: ABEO) added to Russell 2000 Value-Defensive Index - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Abeona Therapeutics Inc.(NasdaqCM:ABEO) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to revenue forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to earnings forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to sales forward of Abeona Therapeutics, Inc. – HAM:PCJ - TradingView
ABEO Should I Buy - Intellectia AI
Enterprise value to EBITDA forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to earnings forward of Abeona Therapeutics, Inc. – HAM:PCJ - TradingView
Enterprise value to EBIT forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Price to book forward of Abeona Therapeutics Inc. – NASDAQ:ABEO - TradingView
Top Growth Companies With Strong Insider Ownership For June 2026 - simplywall.st
Trading the Move, Not the Narrative: (ABEO) Edition - Stock Traders Daily
Abeona Therapeutics Inc (ABEO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Abeona Therapeutics Inc (ABEO) Institutional Confidence - TradingKey
Abeona Therapeutics Inc (ABEO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Abeona Therapeutics Inc (ABEO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Abeona Therapeutics Inc (ABEO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Abeona Therapeutics Inc (ABEO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Abeona Therapeutics Inc (ABEO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Abeona Therapeutics Inc (ABEO) Valuation: PE, PB & Fair Value Analysis - TradingKey
Abeona Therapeutics (NASDAQ: ABEO) CCO has shares withheld for taxes on RSU vesting - Stock Titan
Abeona Therapeutics Inc Azioni (ABEO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):